Quarterly report pursuant to Section 13 or 15(d)

Subsequent Events - Additional Information (Details)

v3.21.1
Subsequent Events - Additional Information (Details)
$ in Millions
Apr. 14, 2021
USD ($)
2018 Merck Agreement | Subsequent Event  
Subsequent Event [Line Items]  
Milestone payment receivable upon initiation of IND enabling toxicology study $ 15